Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FMAPZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,605
Award facts
- Contract value 100% obligated
- $21,605.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,605.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on October 21, 2025, with completion expected by October 22, 2025. This non-competitive delivery order was executed without a set-aside designation and represents a direct fulfillment of pharmaceutical supply requirements under the vendor's existing indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its extensive relationships with the Defense Logistics Agency's medical supply chain to deliver brand-name and specialty medications.
This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. The current award for Dupixent, a specialty pharmaceutical indicated for certain inflammatory conditions, exemplifies the contract's application in delivering high-value specialty medications to support federal medical needs.
Quick answers
Who was awarded contract SPE2DB26FMAPZ?
SPE2DB26FMAPZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FMAPZ worth?
The government has obligated $21,605 on SPE2DB26FMAPZ.
Is contract SPE2DB26FMAPZ an order under another contract?
Yes. SPE2DB26FMAPZ is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMAPZ competed?
The extent of competition for SPE2DB26FMAPZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award